Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Merck
Dow
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

TACLONEX Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Taclonex, and what generic alternatives are available?

Taclonex is a drug marketed by Leo Pharma As and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has ninety-six patent family members in thirty-two countries.

The generic ingredient in TACLONEX is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.

Drug patent expirations by year for TACLONEX
Drug Prices for TACLONEX

See drug prices for TACLONEX

Recent Clinical Trials for TACLONEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Taro Pharmaceuticals USAPhase 1
Glenmark Pharmaceuticals Ltd. IndiaPhase 3
Tolmar Inc.Phase 1

See all TACLONEX clinical trials

Recent Litigation for TACLONEX

Identify potential future generic entrants

District Court Litigation
Case NameDate
LEO Pharma A/S v. Tolmar Inc.2010-08-25
LEO Pharma A/S v. Tolmar Inc.2010-04-06
Bone Care International LLC v. Pentech Pharmaceuticals, Inc.2008-02-21

See all TACLONEX litigation

Pharmacology for TACLONEX
Paragraph IV (Patent) Challenges for TACLONEX
Tradename Dosage Ingredient NDA Submissiondate
TACLONEX OINTMENT;TOPICAL betamethasone dipropionate; calcipotriene 021852 2010-03-31

US Patents and Regulatory Information for TACLONEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 021852-001 Jan 9, 2006 AB RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TACLONEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 021852-001 Jan 9, 2006   Start Trial   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 022185-001 May 9, 2008   Start Trial   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 021852-001 Jan 9, 2006   Start Trial   Start Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene OINTMENT;TOPICAL 021852-001 Jan 9, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Baxter
Merck
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.